Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

November 21, 2022

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Amyloidosis, HereditaryAmyloidosis CardiacAmyloidosis, FamilialTransthyretin-Related (ATTR) Familial Amyloid CardiomyopathyTransthyretin Gene Mutation
Trial Locations (3)

10032

RECRUITING

Columbia University Medical Center, New York

44195

RECRUITING

Cleveland Clinic, Cleveland

75390

RECRUITING

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

The Cleveland Clinic

OTHER

collaborator

Columbia University

OTHER

collaborator

The University of Texas at Arlington

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Texas Southwestern Medical Center

OTHER